Rezo Therapeutics

Rezo Therapeutics is a biotechnology company focused on revolutionizing drug discovery by mapping and therapeutically targeting disease networks. Their unique approach, called Sequence to Systems to Drugs (SSD), integrates data from proteomics, genetics, structural biology, chemistry, and bioinformatics to create comprehensive maps of molecular disease networks. This allows them to identify novel, druggable targets that can be attacked with a range of treatment modalities, potentially leading to the development of truly novel therapeutics.

Rezo's initial focus is in oncology, specifically identifying how mutations rewire cancer-driving networks to uncover tumor-specific therapeutic targets. Their mission is to break the mold in traditional drug development, which is slow and often siloed, by leveraging a fully integrated, disease-agnostic, network biology platform. Founded by a team of renowned scientists from the University of California, San Francisco, Rezo has secured $78 million in Series A funding from top-tier investors to support their innovative approach.

Rezo Therapeutics offers a flexible work schedule and discretionary time off for all full-time employees. Their benefits package includes medical, dental, and vision insurance, a 401(k) retirement savings program, commuter benefits, and flexible spending accounts. The company also provides parental leave and a competitive compensation package. Rezo values a diverse, equitable, and inclusive workplace and provides equal employment opportunity to all.

Rezo Therapeutics offers a comprehensive benefits package to its employees, including medical, dental, and vision insurance, a discretionary time off policy, company holidays, a 401(k) retirement savings program, a commuter/mass transit benefit program, healthcare and dependent care flexible spending accounts, parental leave, competitive compensation, and a flexible work schedule.

Rezo Therapeutics is a biotechnology company dedicated to revolutionizing drug discovery by building a comprehensive, disease-agnostic network biology platform. Their mission is to dramatically increase the success rate of drug development by integrating technologies in genetics, proteomics, structural biology, and AI to create deep biological insights and novel therapeutic approaches, ultimately redefining our understanding of human disease and the ability to treat it.

Rezo Therapeutics fosters a collaborative, respectful, and diverse workplace where team science is valued. They emphasize contributing to team success as much as individual achievements, creating a supportive environment for those passionate about pushing the boundaries of drug development. Their proximity to UCSF and numerous urban amenities provides a vibrant and engaging environment for their employees.

Rezo Therapeutics is committed to creating a diverse, equitable, and inclusive workplace where all individuals feel valued, respected, and have equal opportunities to contribute and succeed. They believe that a diverse workforce enhances innovation, creativity, and problem-solving, leading to better scientific breakthroughs and drug development. Rezo actively promotes equal employment opportunity for all, regardless of race, color, sex, gender identity, gender expression, religion, age, national origin, ancestry, citizenship, physical or mental disability, medical condition, family care status, marital status, domestic partner status, sexual orientation, genetic information, military or veteran status, or any other basis protected by federal, state, or local laws.